Healthcare -
Biotechnology - NASDAQ - NL
$ 23.55
0.555 %
$ 2.52 B
Market Cap
-10.66
P/E
Price Target
Average
76.22%
Revenue Forecast
Estimate
206.99%
EBIT
Estimate
36.40%
Net Income
Estimate
63.55%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
NewAmsterdam Pharma Company N.V.
Wall Street analysts predict an average 1-year price target for NAMS of $41.5 , with forecasts ranging from
a
low of
$36 to a high of $48 .
NAMS Lowest Price Target
Wall Street Target
36 USD
52.87%
NAMS Average Price Target
Wall Street Target
41.5 USD
76.22%
NAMS Highest Price Target
Wall Street Target
48 USD
103.82%
REVENUE FORECAST
Revenue Forecast Chart NAMS
EBIT FORECAST
EBIT Forecast Chart NAMS
NET INCOME FORECAST
Net Income Chart NAMS